Venus Concept, Inc. (VERO)
0.3105
0.00 (0.00%)
USD |
OTCM |
Apr 07, 16:00
Venus Concept EPS Diluted (Quarterly) : -12.14 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | -12.14 |
| June 30, 2025 | -8.034 |
| March 31, 2025 | -17.44 |
| December 31, 2024 | -11.23 |
| September 30, 2024 | -1.280 |
| June 30, 2024 | -3.046 |
| March 31, 2024 | -1.680 |
| December 31, 2023 | -2.010 |
| September 30, 2023 | -1.641 |
| June 30, 2023 | -1.354 |
| March 31, 2023 | -1.851 |
| December 31, 2022 | -2.113 |
| September 30, 2022 | -3.357 |
| June 30, 2022 | -2.470 |
| March 31, 2022 | -2.020 |
| December 31, 2021 | -12.80 |
| September 30, 2021 | -2.714 |
| June 30, 2021 | 0.1042 |
| March 31, 2021 | -2.584 |
| December 31, 2020 | -5.146 |
| Date | Value |
|---|---|
| September 30, 2020 | -2.685 |
| June 30, 2020 | -5.922 |
| March 31, 2020 | -25.25 |
| December 31, 2019 | -15.99 |
| September 30, 2019 | -4378.37 |
| June 30, 2019 | -3062.66 |
| March 31, 2019 | -182.16 |
| December 31, 2018 | -6856.69 |
| September 30, 2018 | -45.38 |
| June 30, 2018 | -47.25 |
| March 31, 2018 | -58.50 |
| December 31, 2017 | -9.00 |
| September 30, 2017 | -51.33 |
| June 30, 2017 | -38.69 |
| March 31, 2017 | -39.99 |
| December 31, 2016 | -422.01 |
| September 30, 2016 | -507.15 |
| June 30, 2016 | -39.97 |
| March 31, 2016 | -44.92 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Hypertension Diagnostics, Inc. | -- |
| Avitar, Inc. | -- |
| Abbott Laboratories | 0.5293 |
| AngioDynamics, Inc. | -0.1689 |
| Alphatec Holdings, Inc. | -0.0348 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.55M |
| Revenue (Quarterly) | 13.78M |
| Total Expenses (Quarterly) | 36.34M |